COVID-19 ETS Survey

NPGA is collecting feedback from members on the potential impact of OSHA's proposal "COVID-19 Vaccination and Testing Emergency Temporary Standard". The proposal serves two functions: it formally promulgates the Emergency Temporary Standard published on November 5th, and the proposal solicits feedback on possibly expanding some provisions of the ETS to businesses with less than 100 employees.

We ask for your responses to the below questions as applicable to your business and employees.

NPGA will aggregate the information received to shape our response to the proposal. Any information presented to OSHA will represent overall industry information; not any individual company.

Question Title

* 1. As of November 5th, how many employees work at your company corporate-wide? By "employees", we mean full- and part-time as well as seasonal workers. Do not include independent contractors.

100 or more

99 to 51

50 to 26

25 to 1

Question Title

* 2. Prior to OSHA's Emergency Temporary Standard, had your company developed and implemented a vaccination or testing and face-covering policies?

Yes, we had an active policy before OSHA's ETS

Yes, we had a policy but ended it before OSHA's ETS

No, we did not have a policy

Question Title

* 3. If your company already implemented a vaccination policy, please select which of the below describe it.

Mandatory vaccination of all employees.

Voluntary vaccination or periodic testing and face-coverings required.

Testing based on exposure.

Face-coverings required when mandated by state or local laws.

Face-coverings required when interacting with customers.

Space distancing when indoors.

Company provided on-site vaccination.

Paid leave for vaccination appointments.

Paid leave for recovering from vaccination symptoms.

Proof of vaccination status, such as vaccination card or appointment receipt.

Company supplied testing.

Company administered testing.

Paid leave for employees who test positive for COVID-19.

Minimum criteria for face-coverings, when required.

Question Title

* 4. If your company developed and implemented a vaccination or testing and face-covering policy, rate its effectiveness in reducing COVID-19 exposures or transmission at your workplace?

Unclear

Yes

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 5. If your company implemented a vaccination policy, what aspects were ineffective at reducing transmission of COVID-19 among employees?

Mandatory vaccination of all employees.

Voluntary vaccination or periodic testing and face-coverings required.

Testing based on exposure.

Face-coverings required when mandated by state or local laws.

Face-coverings required when interacting with customers.

Space distancing when indoors.

Company provided on-site vaccination.

Paid leave for vaccination appointments.

Paid leave for recovering from vaccination symptoms.

Proof of vaccination status, such as vaccination card or appointment receipt.

Company supplied testing.

Company administered testing.

Paid leave for employees who test positive for COVID-19.

Minimum criteria for face-coverings, when required.

Question Title

* 6. If your company developed and implemented a policy on vaccination or testing and face-coverings, what challenges did you encounter?

Question Title

* 7. If the ETS applies to your company - or OSHA extends the ETS to apply to your company - what challenges do you expect?

Increasing business expenses to pay for testing

Staff opposition to policies

Staff resignation in opposition to policies

Disruption to customer services due to understaffing

Consumer questions on employees' vaccination status

Other (please specify)

None of the above, I don't anticipate challenges

Question Title

* 8. Assuming your company must develop and implement a testing and face-covering requirement, what costs do you anticipate to test each employee every 7 days?

$15-20 per test per employee

$25-$50 per test per employee for recordkeeping and administration

$10 per employee per week in face-coverings

Other (please specify)

Question Title

* 9. Since March 2020, what percentage of COVID-19 positive cases among your employees occurred at the workplace? By workplace, include all locations where employees are responsible for carrying out work functions as assigned.

0-10%

11-20 %

21-30%

31-40%

41-50%

51-60%

61-70%

71-80%

81-90%

91-100%

Question Title

* 10. Has your company found any difficulty in determining whether an employee's COVID-19 exposure occurred at the workplace or outside the workplace?

Yes, it is impossible

It is difficult but manageable

No, it is simple

Question Title

* 11. OSHA is considering to mandate that all employers require all employees are fully vaccinated against COVID-19 without an alternative for testing and face-coverings. How would this impact your company and employees?